Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...

Chemical companies in the US and Europe began exiting the pharmaceutical industry in the mid-1990s, when the British firm ICI ...

Private equity firm Bain Capital agreed to acquire Mitsubishi ... Sciences. Tanabe Pharma will continue to build on its legacy of medical innovation while boosting growth via business development ...

Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group's Pharmaceutical subsidiary, Mitsubishi Tanabe Pharma ... been reassessing its business portfolio to ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

Mitsubishi Chemical Group Corp. (MCG; Tokyo) announced that it has decided to transfer its consolidated subsidiary Mitsubishi Tanabe Pharma Corp. (MTPC; ...

The investment is being led by Bain Capital’s Private Equity teams in Asia and North America together with the firm’s Life Sciences team and values the business at approximately ... to Bain Capital.

Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group’s pharmaceutical subsidiary, Mitsubishi Tanabe Pharma ... Mitsubishi Chemical has been reassessing its business ...